SERPINE2
SERPINE2 (serpin family E member 2), also known as glia-derived nexin, PN1, GDN, PNI, nexin and PI7, is a secreted serine protease inhibitor of the serpin family. It acts on thrombin, trypsin and urokinase, and promotes neurite extension. Browse Assay Genie's current range of SERPINE2 research reagents below, or read on for the biology behind the target.
SERPINE2 is a serine protease inhibitor with activity toward thrombin, trypsin and urokinase. The NCBI Gene summary also lists plasmin among the proteases that this family member can inhibit. By inhibiting thrombin, the SERPINE2 protein promotes neurite extension, which accounts for its original description as glia-derived nexin. It also binds heparin.
The protein belongs to the serpin family, a group of proteins that inhibit serine proteases, and it is found in the extracellular space as a secreted protein. The SERPINE2 gene sits in the HGNC group of serpin peptidase inhibitors. Alternative splicing of the gene results in multiple transcript variants. Mouse and rat each have an orthologous Serpine2 gene, so the protein can be studied in common rodent models.
The gene has been known under several names: PN1, GDN, PNI, nexin and PI7. Earlier HGNC names described it as a serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2, and as serpin peptidase inhibitor, clade E, member 2. In terms of disease relevance, SERPINE2 is described as a susceptibility gene for chronic obstructive pulmonary disease and for emphysema. Researchers working on protease regulation, neurite outgrowth or lung disease genetics therefore often study SERPINE2, whether they are measuring the SERPINE2 protein or analysing the gene.
SERPINE2 inhibits thrombin, trypsin, urokinase and plasmin, making it a useful model for serpin-protease interactions.
By inhibiting thrombin, SERPINE2 promotes neurite extension, which links it to studies of neural outgrowth.
SERPINE2 is a susceptibility gene for chronic obstructive pulmonary disease and for emphysema.
SERPINE2 binds heparin, so it is relevant to work on how glycosaminoglycans interact with serpins.
SERPINE2 is a secreted serine protease inhibitor. It acts on thrombin, trypsin and urokinase, and NCBI also lists plasmin. By inhibiting thrombin it promotes neurite extension. It also binds heparin. Check the datasheet of any product for its validated reactivity.
SERPINE2 is also called glia-derived nexin, PN1, GDN, PNI, nexin and PI7. Older HGNC names describe it as serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2. Alternative splicing gives multiple transcript variants.
SERPINE2 is described as a susceptibility gene for chronic obstructive pulmonary disease and for emphysema. Mouse and rat both have an orthologous Serpine2 gene, which supports its study in rodent models. Check the datasheet of any product for its validated reactivity.
Other serpins, target proteases such as thrombin and urokinase, and fibrinolysis-pathway proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P07093; product specifications from Assay Genie datasheets.